sixty-six outpatients with active ulcerative colitis who were intolerant of sulphasalazine were treated in a double-blind randomized trial with placebo or olsalazine in daily doses of 0.75 , 1.5 , or 3 g .
C0009324
ulcerative colitis
C0069454
daily doses